David Pascoe

David Pascoe started the Rosacea Support Group in October 1998.

Rosacea is linked to migraines in women

Rosacea is linked to migraines in women

A just published paper has found a statistical link between rosacea and migraines. Specifically, the research has found that female rosacea sufferers over the age of 50 had a `significantly higher prevalence and risk of incident migraine’. So what might we learn about treating both rosacea and migraines from this research? The takeaways from this […]

Continue Reading

Dermata DMT 210 works for redness and bumps of rosacea

Written by on September 29, 2016 in clinical trials, New Rosacea Treatments with 3 Comments
Dermata DMT 210 works for redness and bumps of rosacea

A press release today highlighting a new drug, based on Arazine, that is claimed to help both the redness and papules and pustules of rosacea through its ability to down regulate G-protein coupled receptor (GPCR) signaling. The company developing DMT 210, Dermata, is releasing results from their phase 1 trials, and are looking to commence phase 2 trials […]

Continue Reading

Probiotics and Oracea for Scalp Rosacea

Probiotics and Oracea for Scalp Rosacea

  This paper details a rosacea sufferer who suffered from rosacea lesions on his scalp, and was successfully treated with 8 weeks of Oracea and twice daily probiotics. The rosacea extended to a lesser extent to his cheeks and nose, and he also suffered from blepharitis and conjuctivitis. The patient ceased Oracea, but continuted with […]

Continue Reading

Sunscreens: don’t be fooled by Amazon Reviews

Written by on August 25, 2016 in in the news, Sunscreens for Rosacea Sufferers with 2 Comments
Sunscreens: don’t be fooled by Amazon Reviews

A really insightful article in The Atlanta Journal Constitution highlights how we might be fooled by what we find on the internet. Researchers examined 65 sunscreen products that were reviewed positively on amazon.com for their performance as a sunscreen. The performance of a sunscreen is something we can measure. The AAD has minimum requirements that […]

Continue Reading

Soolantra sales growing by 36%

Soolantra sales growing by 36%

Sales figures for rosacea prescription products are generally hard to come by. This is about as public as they get – the owners of Galderma, Nestle are touting how well Soolantra sales growth is contributing to their profits. Nestlé (NSRGY) Q2 2016 Results – Earnings Call Transcript In Nestlé skin health, we have a consumer […]

Continue Reading

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.